Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
Alias
More Information
Pimozida; 3-[1-[4,4-Bis(4-Fluorophenyl)Butyl]Piperidin-4-Yl]-1H-Benzimidazol-2-One; Neoperidole; Pimozidum; Orap; Mcn-Jr-6238; Opiran; 1-[1-[4,4-Bis(4-Fluorophenyl)Butyl]-4-Piperidinyl]-1,3-Dihydro-2H-Benzimidazol-2-One
Brief Introduction
Pimochet is also called pimochet. Pimozide is a diphenylbutylpyridine antipsychotic. It has a good effect on mania, hallucination, delusion, indifference and withdrawal, especially for patients with chronic withdrawal. The drug also has some degree of calcium antagonism. The indications are applicable to acute and chronic schizophrenia, paranoid state, single symptom hypochondriasis and Tourette syndrome.
CAS:207233-91-8
Molecular Formula:C3H9NaO4S3
Alias
More Information
2,3-Dichloro-5-Hydroxypyridine; 2,3-Dimercaptopropanesulfonic Acid Sodium Salt Monohydrate,Dmps; Sodium Dl-2,3-Dithiopropanesulphonate Monohydrate; 2,3-Dimercaptopropanesulfonic Acid Sodium Salt Monohydrate Dmps; Sodium 2,3-Dimercaptopropanesulfonate Monohydrate; 2,3-Dimercapto-1-Propanesulfonic Acid Sodium Salt Monohydrate; Dl-2,3-Dimercapto-1-Propanesulfonic Acid,Sodium Salt Monohydrate; Mfcd00149543
Brief Introduction
Rubber and pharmaceutical industries. Antidote for heavy metal poisoning.
CAS:208110-64-9
Molecular Formula:C20H22ClF2N3O
Alias
More Information
Unii-Rat9Oha1Yh; Befiradol; Nlx-112; Rat9Oha1Yh
Brief Introduction
Befiradol (F-13,640; NLX-112) is a very potent and highly selective 5-HT1A receptor full agonist. It has powerful analgesic and antiallodynic effects comparable to those of high doses of opioid painkillers, but with fewer and less prominent side effects, as well as little or no development of tolerance with repeated use. A SAR study revealed that replacement of the dihalophenyl moiety by 3-benzothienyl increases maximal efficacy from 84% to 124% (Ki=2.7 nM).
Befiradol was discovered and developed by Pierre Fabre Médicament, a French pharmaceuticals company. In September 2013, befiradol was out-licensed to Neurolixis, a California-based biotechnology company. Neurolixis announced that it intends to re-purpose befiradol for the treatment of Levodopa-induced dyskinesia in Parkinson's disease. In support of this indication, preclinical data was published describing the activity of befiradol in animal models of Parkinson's disease.
CAS:20830-81-3
Molecular Formula:C27H29NO10
Alias
More Information
(8S-Cis)-8-Acetyl-10-((3-Amino-2,3,6-Trideoxy-Alpha-L-Lyxo-Hexopyranosyl)Oxy)-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-1-Methoxy-5,12-Naphthacenedione Hydrochloride; Daunorubicine Hydrochloride; Daunomycin Hydrochloride; Leukaemomycin C Hydrochloride; (8S-Cis)-8-Acetyl-10-[(3-Amino-2,3,6-Trideoxy-Alpha-L-Lyxo-Hexopyrannosyl)Oxy]; 3-Acetyl-1,2,3,4,6,11-Hexahydro-3,5,12-Trihydroxy-10-Methoxy-6,11-Dioxo-1-Naph
Brief Introduction
Daunorubicin is an anthracycline antibiotic that has antineoplastic activity and is used in the therapy of acute leukemia and AIDS related Kaposi sarcoma. Daunorubicin is associated with a low rate of transient serum enzyme and bilirubin elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury with jaundice.
CAS:208538-73-2
Molecular Formula:C56H70N9NaO23S
Alias
More Information
Pneumocandin A0, 1-[(4R,5R)-4,5-Dihydroxy-N2-[4-[5-[4-(Pentyloxy)Phenyl]-3-Isoxazolyl]Benzoyl]-L-Ornithine]-4-[(4S)-4-Hydroxy-4-[4-Hydroxy-3-(Sulfooxy)Phenyl]-L-Threonine]-, Sodium Salt (1:1); 1-[(4R,5R)-4,5-Dihydroxy-N2-[4-[5-[4-(Pentyloxy)Phenyl]-3-Isoxazolyl]Benzoyl]-L-Ornithine]-4-[(4S)-4-Hydroxy-4-[4-Hydroxy-3-(Sulfooxy)Phenyl]-L-Threonine]Pneumocandin A0 Monosodium Salt; Funguard; Micafungin Sodium(Fk-463, Mycamine); Mycamine; Cs-705; Fk 463; Funguard; Mycamine; Micafungin Sodium Impurity
Brief Introduction
Micafungin sodium is the second echinocandin drug used in clinic after caspofungin. It is an antifungal drug developed by Estelle company of Japan. It was first listed in Japan in 2002 and approved by FDA in the United States in May 2005. Its indications are mycosis caused by Aspergillus and Candida, respiratory mycosis and gastrointestinal mycosis. In addition, amphotericin and triazole antifungal drugs were used in combination.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!